fluconazole has been researched along with Leukemia, Promyelocytic, Acute in 10 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we discuss about the diagnosis and treatment process of the IIH emerging in a young acute promyelocytic leukemia (APL) case with the ATRA impact, which can be increased by posaconazole." | 8.12 | Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia. ( Atas, U; Aydin Ersoy, M; Iltar, U; Salim, O; Turkoglu, EB; Yucel, OK, 2022) |
| "We describe 2 patients with acute promyelocytic leukemia (APL) in whom torsade de pointes (TdP) developed during treatment with arsenic trioxide." | 7.73 | Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapy. ( Kobayashi, M; Naito, K; Nakamura, S; Ohnishi, K; Ohno, R; Sahara, N; Shigeno, K; Shinjo, K; Takeshita, A; Tobita, T, 2006) |
| "All-trans-retinoic acid induces acute promyelocytic leukemia cell differentiation in vitro, and it produces greater than 90% complete remissions in patients with acute promyelocytic leukemia." | 5.29 | Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia. ( Gallagher, RE; Hallam, S; Schwartz, EL; Wiernik, PH, 1995) |
| " Here, we discuss about the diagnosis and treatment process of the IIH emerging in a young acute promyelocytic leukemia (APL) case with the ATRA impact, which can be increased by posaconazole." | 4.12 | Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia. ( Atas, U; Aydin Ersoy, M; Iltar, U; Salim, O; Turkoglu, EB; Yucel, OK, 2022) |
| "We describe 2 patients with acute promyelocytic leukemia (APL) in whom torsade de pointes (TdP) developed during treatment with arsenic trioxide." | 3.73 | Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapy. ( Kobayashi, M; Naito, K; Nakamura, S; Ohnishi, K; Ohno, R; Sahara, N; Shigeno, K; Shinjo, K; Takeshita, A; Tobita, T, 2006) |
| " One patient had developed a chronic systemic candidiasis during consolidation chemotherapy and received prophylactic oral or iv fluconazole (200 mg daily) throughout BMT." | 3.69 | Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases. ( Altés, A; Brunet, S; Domingo-Albós, A; Martínez, C; Martino, R; Nomdedéu, J; Sureda, A, 1994) |
| "The patient was diagnosed as having acute promyelocytic leukemia microgranular type (M3v) and was therefore administered all-trans retinoic acid (ATRA)." | 1.35 | [Hypercalcemia associated with all-trans retinoic acid therapy for microgranular type acute promyelocytic leukemia]. ( Hisatake, J; Shimozuma, J, 2008) |
| "All-trans-retinoic acid induces acute promyelocytic leukemia cell differentiation in vitro, and it produces greater than 90% complete remissions in patients with acute promyelocytic leukemia." | 1.29 | Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia. ( Gallagher, RE; Hallam, S; Schwartz, EL; Wiernik, PH, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atas, U | 1 |
| Aydin Ersoy, M | 1 |
| Iltar, U | 1 |
| Yucel, OK | 1 |
| Turkoglu, EB | 1 |
| Salim, O | 1 |
| Hisatake, J | 1 |
| Shimozuma, J | 1 |
| Vanier, KL | 1 |
| Mattiussi, AJ | 1 |
| Johnston, DL | 1 |
| Allione, A | 1 |
| Montanaro, M | 1 |
| Marmont, F | 1 |
| Pomero, F | 1 |
| Porta, M | 1 |
| Naito, K | 1 |
| Kobayashi, M | 1 |
| Sahara, N | 1 |
| Shigeno, K | 1 |
| Nakamura, S | 1 |
| Shinjo, K | 1 |
| Tobita, T | 1 |
| Takeshita, A | 1 |
| Ohno, R | 1 |
| Ohnishi, K | 1 |
| Yarali, N | 1 |
| Tavil, B | 1 |
| Kara, A | 1 |
| Ozkasap, S | 1 |
| Tunç, B | 1 |
| Schwartz, EL | 1 |
| Hallam, S | 1 |
| Gallagher, RE | 1 |
| Wiernik, PH | 1 |
| Seki, H | 1 |
| Seno, A | 1 |
| Sakazume, S | 1 |
| Shinoda, K | 1 |
| Shintani, N | 1 |
| Wada, T | 1 |
| Wada, H | 1 |
| Koizumi, S | 1 |
| Taniguchi, N | 1 |
| Horita, S | 1 |
| Martino, R | 1 |
| Nomdedéu, J | 1 |
| Altés, A | 1 |
| Sureda, A | 1 |
| Brunet, S | 1 |
| Martínez, C | 1 |
| Domingo-Albós, A | 1 |
| Smith, KJ | 1 |
| Welsh, M | 1 |
| Skelton, H | 1 |
1 trial available for fluconazole and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
[Clinical study of fluconazole-injectable and -granules in pediatric patients].
Topics: Administration, Oral; Anemia, Aplastic; Aspergillosis; Candidiasis; Fluconazole; Humans; Injections, | 1994 |
9 other studies available for fluconazole and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia.
Topics: Adult; Fluconazole; Humans; Leukemia, Promyelocytic, Acute; Male; Papilledema; Pseudotumor Cerebri; | 2022 |
[Hypercalcemia associated with all-trans retinoic acid therapy for microgranular type acute promyelocytic leukemia].
Topics: Adult; Antineoplastic Agents; Drug Interactions; Drug Therapy, Combination; Fluconazole; Humans; Hyp | 2008 |
Interaction of all-trans-retinoic acid with fluconazole in acute promyelocytic leukemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cytochrome P-450 Enzyme System; Drug Interactions; Femal | 2003 |
Fungal endophthalmitis in acute leukaemia.
Topics: Acute Disease; Adult; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Human | 2004 |
Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapy.
Topics: Adult; Anthracyclines; Antifungal Agents; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cardi | 2006 |
Acute renal failure during ATRA treatment.
Topics: Acute Kidney Injury; Adolescent; Antifungal Agents; Antineoplastic Agents; Female; Fluconazole; Huma | 2008 |
Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia.
Topics: Adult; Antifungal Agents; Drug Interactions; Female; Fluconazole; Humans; In Vitro Techniques; Leuke | 1995 |
Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Aspergillosis; Aspergillus; Bone Marrow Tra | 1994 |
Trichophyton rubrum showing deep dermal invasion directly from the epidermis in immunosuppressed patients.
Topics: Adolescent; Adult; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Combi | 2001 |